Abstract
99mTc tricarbonyl glycine monomers, trimers, and pentamers were synthesized and evaluated for their radiolabeling and in vivo distribution characteristics. We synthesized a 99mTc-tricarbonyl precursor with a low oxidation state (I). 99mTc(CO)3(H2O)3+ was then made to react with monomeric and oligomeric glycine for the development of bifunctional chelating sequences for biomolecules. Labeling yields of 99mTc-tricarbonyl glycine monomers and oligomers were checked by high-performance liquid chromatography. The labeling yields of 99mTc-tricarbonyl glycine and glycine oligomers were more than 95%. We evaluated the characteristics of 99mTc-tricarbonyl glycine oligomers by carrying out a lipophilicity test and an imaging study. The octanol-water partition coefficient of 99mTc tricarbonyl glycine oligomers indicated hydrophilic properties. Single-photon emission computed tomography imaging of 99mTc-tricarbonyl glycine oligomers showed rapid renal excretion through the kidneys with a low uptake in the liver, especially of 99mTc tricarbonyl triglycine. Furthermore, we verified that the addition of triglycine to prototype biomolecules (AGRGDS and RRPYIL) results in the improvement of radiolabeling yield. From these results, we conclude that triglycine has good characteristics for use as a bifunctional chelating sequence for a 99mTc-tricarbonyl- based biomolecular imaging probe.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alberto, R., Schibli, R., Schubiger, P.A., Abram, U. and Kaden, T.A. (1996). Reactions with the technetium and rhenium carbonyl complexes (NEt4)2[MX3(CO)3]. Synthesis and structure of [Tc(CN-Bu)3(CO)3](NO3) and (NEt4)[Tc2(M-SCH2CH2OH)3(CO)6]. Poly., 15, 1079–1089.
Alberto, R., Schibli, R., Egli, A., Schubiger, P.A., Abram, U. and Kaden, T.A. (1998). A novel organometallic aqua complex of technetium for the labeling of biomolecules: synthesis of 99mTc(OH2)3(CO)3+ from [99mTcO4]- in aqueous solution and its reaction with a bifunctional ligand. J. Am. Chem. Soc., 120, 7987–7988.
Chen, W.J., Yen, C.L., Lo, S.T., Chen, K.T. and Lo, J.M. (2008). Direct 99mTc labeling of Herceptin (trastuzumab) by 99mTc(I) tricarbonyl ion. Appl. Radiat. Isot., 66, 340–345.
Egli, A., Alberto, R., Tannahill, L., Schibli, R., Abram, U., Schaffland, A., Waibel, R., Tourwé, D., Jeannin, L., Iterbeke, K. and Schubiger, P.A. (1999). Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity. J. Nucl. Med., 40, 1913–1917.
Fischman, A.J., Babich, J.W. and Strauss, H.W. (1993). A ticket to ride: peptide radiopharmaceuticals. J. Nucl. Med., 34, 2253–2263.
Lee, S., Xie, J. and Chen, X. (2010). Peptides and peptide hormones for molecular imaging and disease diagnosis. Chem. Rev., 110, 3087–3111.
Liu, G., Dou, S., He, J., Yin, D., Gupta, S., Zhang, S., Wang, Y., Rusckowski, M. and Hnatowich, D.J. (2006). Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting. Appl. Radiat. Isot., 64, 971–978.
Maresca, K.P., Marquis, J.C., Hillier, S.M., Lu, G., Femia, F.J., Zimmerman, C.N., Eckelman, W.C., Joyal, J.L. and Babich, J.W. (2010). Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide. Bioconjugate Chem., 21, 1032–1042.
McAfee, J.G. and Neumann, R.D. (1996). Radiolabeled peptides and other ligands for receptors overexpressed in tumor cells for imaging neoplasms. Nucl. Med. Biol., 23, 673–676.
Park, S.H., Jang, B.S. and Park, K.B. (2005). Synthesis and biological characteristics of 99mTc(I) tricarbonyl cysteine, a potential diagnostic for assessment of renal function. J. Labelled Compd. Radiopharm., 48, 63–73.
Psimadas, D., Fani, M., Gourni, E., Loudos, G., Xanthopoulos, S., Zikos, C., Bouziotis, P. and Varvarigou, A.D. (2012). Synthesis and comparative assessment of a labeled RGD peptide bearing two different 99mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical. Bioorg. Med. Chem., 20, 2549–2557.
Reubi, J.C. (1995). Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging. J. Nucl. Med., 36, 1825–1835.
Schibli, R., Alberto, R., Abram, U., Egli, A., Schubiger, P.A. and Kaden, T.A. (1998). Structural and 99Tc-NMR investigations of complexes with fac-[Tc(CO)3]+ moieties and macrocyclicthioethers of various ring size: synthesis and X-ray structure of the complexes fac-[Tc(9-ane-S3)(CO)3]Br, fac-[Tc2(tosylate)2(18-ane-S6)(CO)6] and fac-[Tc2(20-ane-S6-OH)(CO)6][tosylate]2. Inorg. Chem., 37, 3509–3516.
Schibli, R., Katti, K.V., Volkert, W.A. and Barnes, C.L. (2001). Development of novel water-soluble, organometallic compounds for potential use in nuclear medicine: systhesis, characterization, and (1)H and (31)P NMR investigations of the complexes fac-[ReBr3(CO)3L](L=bis(bis(hydroxymethyl)phospino) ethane, bis(bis(hydroxymethyl)phosphine)bezene). Inorg. Chem., 40, 2358–2362.
Schibli, R., La Bella, R., Alberto, R., Garcia-Garayoa, E., Ortner, K., Abram, U. and Schubiger, P.A. (2000). Influence of the denticity of ligand systems on the in vitro and in vivo behavior of 99mTc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. Bioconjugate Chem., 11, 345–351.
Taylor, A.T., Lipowska, M. and Marzilli, L.G. (2010). 99mTc(CO)3(NTA): a 99mTc renal tracer with pharmacokinetic properties comparable to those of 131I-OIH in healthy volunteers. J. Nucl. Med., 51, 391–396.
Vanderheyden, J.L., Liu, G., He, J., Patel, B., Tait, J.F. and Hnatowich, D.J. (2006). Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice. Nucl. Med. Biol., 33, 135–144.
Wang, Y., Liu, X. and Hnatowich, D.J. (2007). An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with 99mTc at room temperature. Nat. Protoc., 2, 972–978.
Zhang, Y.M., Liu, N., Zhu, Z.H., Rusckowski, M. and Hnatowich, D.J. (2000). Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA. Eur. J. Nucl. Med., 27, 1700–1707.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://doi.org/creativecommons.org/licenses/by/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Jang, BS., Lee, JS., Rho, J.K. et al. Biodistribution of 99mTc Tricarbonyl Glycine Oligomers. Toxicol Res. 28, 235–240 (2012). https://doi.org/10.5487/TR.2012.28.4.235
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2012.28.4.235